# FDA Inspection 1221124 - Vitalant - October 24, 2023

Source: https://www.keypedia.com/records/fda_inspections/vitalant/28032229-cded-4322-8a8b-a49de778d75e
Source feed: FDA_Inspections

> FDA Inspection 1221124 for Vitalant on October 24, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1221124
- Company Name: Vitalant
- Inspection Date: 2023-10-24
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1076516 - 2018-12-19](https://www.keypedia.com/records/fda_inspections/vitalant/2e027216-6576-4863-b183-7c7b232a6cbd)
- [FDA Inspection 1028490 - 2017-08-25](https://www.keypedia.com/records/fda_inspections/vitalant/cc673144-cb19-477a-9127-2ed7a04889e8)
- [FDA Inspection 927824 - 2015-04-30](https://www.keypedia.com/records/fda_inspections/vitalant/27e579b6-8fc9-42d9-84b7-e613f75d5c56)
- [FDA Inspection 818297 - 2013-01-30](https://www.keypedia.com/records/fda_inspections/vitalant/66d9ecd1-0128-4784-8b2f-d185bb09b6b0)
- [FDA Inspection 746605 - 2011-09-20](https://www.keypedia.com/records/fda_inspections/vitalant/d51f7f24-e882-42e6-af52-4a36250ddd6f)

Company: https://www.keypedia.com/companies/vitalant/641596d7-7712-4f90-86e8-c1b6b93683dc

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d